Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROHAN A SHAH

Allopathic & Osteopathic Physicians General Practice

NPI
1760045397
CMS profile
11255892
Location
ST PETERSBURG, FL

General Payments · PY2022–2024

$1,425.41

  • Reported across 21 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$878.53

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $878.53 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $246.07 2
Janssen Pharmaceuticals, Inc $181.51 9
GENZYME CORPORATION $162.23 1
Reflow Medical Inc $135.55 1
Inari Medical, Inc. $129.26 1
Amgen Inc. $23.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $25.04 1
PY2023 $521.84 5
PY2024 $878.53 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $121.12 06/27/2024 Food and Beverage Undisputed 01/23/2026 1106066828 CMS
ABBVIE INC. $124.95 12/12/2024 Food and Beverage Undisputed 01/23/2026 1106066830 CMS
Amgen Inc. $23.91 04/11/2024 Food and Beverage Undisputed 01/23/2026 1116107076 CMS
GENZYME CORPORATION $162.23 05/07/2024 Food and Beverage Undisputed 01/23/2026 1139939141 CMS
Inari Medical, Inc. $129.26 06/13/2024 Food and Beverage Undisputed 01/23/2026 1140164053 CMS
Janssen Pharmaceuticals, Inc $3.39 01/06/2024 Food and Beverage Undisputed 01/23/2026 1077984512 CMS
Janssen Pharmaceuticals, Inc $10.27 01/19/2024 Food and Beverage Undisputed 01/23/2026 1077984750 CMS
Janssen Pharmaceuticals, Inc $103.58 02/07/2024 Food and Beverage Undisputed 01/23/2026 1077984748 CMS
Janssen Pharmaceuticals, Inc $10.14 02/16/2024 Food and Beverage Undisputed 01/23/2026 1077984644 CMS
Janssen Pharmaceuticals, Inc $11.11 03/01/2024 Food and Beverage Undisputed 01/23/2026 1077984236 CMS
Janssen Pharmaceuticals, Inc $11.43 05/03/2024 Food and Beverage Undisputed 01/23/2026 1077984426 CMS
Janssen Pharmaceuticals, Inc $8.83 08/16/2024 Food and Beverage Undisputed 01/23/2026 1077984230 CMS
Janssen Pharmaceuticals, Inc $11.22 09/06/2024 Food and Beverage Undisputed 01/23/2026 1077984222 CMS
Janssen Pharmaceuticals, Inc $11.54 09/20/2024 Food and Beverage Undisputed 01/23/2026 1077984516 CMS
Reflow Medical Inc $135.55 02/22/2024 Food and Beverage Undisputed 01/23/2026 1154717198 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.